Home / Auditor changes / SANGAMO THERAPEUTICS, INC
Filed 2026-07-01 路 Form 8-K 路 Accession 0001193125-26-292501 nano
Price before filing: $0.0539 (2026-06-30 close, split/dividend-adjusted)
Market cap at flag: $24.9M (2026-07-01) 路 Latest: $45.7M (2026-10-16)
| Window | SGMOQ | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +35.9% | +0.0% | +35.9% | 2026-07-31 |
| 90 days | +160.0% | +2.6% | +157.4% | 2026-09-29 |
| 180 days | pending | pending | until 2026-12-28 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"At this time, a new independent registered public accounting firm has not been engaged."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: changed
Disagreements reported: no
Why this score: also within 90 days: Going-concern doubt, Late quarterly report (NT 10-Q)
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.